The enhancement of cisplatin sensitivity upon CHKA knockdown in tumor cells might open promising clinical perspectives providing a chance for increasing the treatment efficacy by allowing reduction of the dose of administered drugs and limiting unwanted effects on normal cells. Here, CHKA is linked to neoplasm.